Liquid Biopsy Clinical Research – Tracking Mutations in cfDNA and CTCs

Advances in technology such as automated end-to-end solutions are allowing clinical researchers to study tough liquid biopsy samples. Leaders in the field have designed next- generation sequencing (NGS) assays that target critical questions in cancer research and tumor biology. We recently caught up with Dr. Luca Quagliata, MD, of University Hospital, Basel, Switzerland. We discussed tracking Read the rest of this article

The post Liquid Biopsy Clinical Research – Tracking Mutations in cfDNA and CTCs appeared first on Accelerating Science.

from Biomedical Engineering via ola Kala on Inoreader http://ift.tt/1TNdCfk
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OJsHqz
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1KZWxfG
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1oUa0Md
via IFTTT